Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals & Medical Research Mega (1.3tn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mega (675.0bn) -1–5 -$10M–$100M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals & Medical Research Mega (521.5bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (368.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mega (363.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (305.7bn) 0 No activity — —
CH Novartis AG (NOVN)
Pharmaceuticals & Medical Research Mega (301.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mega (257.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals & Medical Research Mega (249.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mega (249.4bn) 1–5 $10M–$100M 0–15% 0–15%
Pharmaceuticals & Medical Research Mega (208.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mega (201.4bn) 0 No activity — 0–15%
Healthcare Services Large (199.9bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (174.0bn) 0 No activity — 0–15%
Healthcare Services Large (161.7bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (152.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (137.5bn) 0 No activity — 0–15%
Healthcare Services Large (134.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (129.3bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Large (128.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (107.4bn) 0 No activity — 0–15%
Healthcare Services Large (106.9bn) -1–5 -$10M–$100M -0–15% 15–50%
Healthcare Services Large (104.1bn) 1–5 $1M–$10M 0–15% 0–15%
US Moderna Inc (MRNA)
Pharmaceuticals & Medical Research Large (101.5bn) 0 No activity — 0–15%
GB GSK plc (GSK)
Pharmaceuticals & Medical Research Large (100.3bn) 11–20 $100K–$1M 0–15% 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals & Medical Research Large (97.8bn) 0 No activity — 0–15%
Healthcare Services Large (93.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (93.4bn) -1–5 -$10M–$100M -0–15% 0–15%
AU CSL Ltd (CSL)
Pharmaceuticals & Medical Research Large (90.6bn) 0 No activity — 0–15%
Healthcare Services Large (80.4bn) 0 No activity — 0–15%
Healthcare Services Large (79.6bn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Large (77.0bn) 0 No activity — —
Healthcare Services Large (64.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (64.2bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (63.7bn) 0 No activity — 0–15%
DE Bayer AG (BAYN)
Pharmaceuticals & Medical Research Large (62.2bn) 0 No activity — —
Pharmaceuticals & Medical Research Large (62.0bn) 0 No activity — 0–15%
BE Ucb SA (UCB)
Pharmaceuticals & Medical Research Large (61.9bn) 1–5 < $100K 0–15% 15–50%
NL argenx SE (ARGX)
Pharmaceuticals & Medical Research Large (61.1bn) -6–10 -$10M–$100M -0–15% —
Healthcare Services Large (60.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (60.7bn) 0 No activity — 0–15%
Healthcare Services Large (59.7bn) 0 No activity — 0–15%
Healthcare Services Large (58.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (56.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (54.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (52.8bn) -1–5 -$10M–$100M -0–15% 0–15%
US Medline Inc (MDLN)
Healthcare Services Large (52.6bn) -1–5 -$100M+ -0–15% 0–15%
Healthcare Services Large (52.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (50.0bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Large (49.8bn) 0 No activity — 50%+
Healthcare Services Large (46.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (44.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (44.7bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Large (44.3bn) 0 No activity — 0–15%
US Seagen Inc (SGEN)
Pharmaceuticals & Medical Research Large (43.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (39.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (37.7bn) 1–5 $100K–$1M 0–15% 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals & Medical Research Large (36.8bn) 0 No activity — 0–15%
Healthcare Services Large (36.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (36.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (33.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (33.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (32.7bn) -1–5 -$1M–$10M -0–15% 15–50%
DK Genmab A/S (GMAB)
Pharmaceuticals & Medical Research Large (32.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (32.2bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Large (32.0bn) 0 No activity — 50%+
US Dexcom Inc (DXCM)
Healthcare Services Large (31.1bn) 0 No activity — 0–15%
CH Alcon AG (ALC)
Healthcare Services Large (30.8bn) 0 No activity — 0–15%
Healthcare Services Large (29.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (29.2bn) 1–5 -$100K–$1M -0–15% 50%+
Healthcare Services Large (29.1bn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Large (28.9bn) 0 No activity — 0–15%
Healthcare Services Large (28.6bn) 0 No activity — 0–15%
Healthcare Services Large (28.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US Cerner Corp (CERN)
Healthcare Services Large (27.9bn) 0 No activity — 0–15%
Healthcare Services Large (26.8bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (26.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (25.9bn) -1–5 -$10M–$100M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (25.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (25.0bn) -1–5 -$1M–$10M -0–15% 0–15%
US Incyte Corp (INCY)
Pharmaceuticals & Medical Research Large (24.5bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (24.0bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Large (24.0bn) -1–5 -$1M–$10M -0–15% 0–15%
US Viatris Inc (VTRS)
Pharmaceuticals & Medical Research Large (23.9bn) 0 No activity — 0–15%
Healthcare Services Large (23.9bn) 0 No activity — 0–15%
DE Biontech SE (BNTX)
Pharmaceuticals & Medical Research Large (23.1bn) -1–5 -$10M–$100M -0–15% 50%+
Healthcare Services Large (21.2bn) -6–10 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (21.1bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (21.0bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (20.9bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (20.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (20.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (19.4bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Large (18.8bn) -1–5 -$100M+ -0–15% 15–50%
Healthcare Services Large (18.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (18.4bn) 1–5 $100K–$1M 0–15% 15–50%
Healthcare Services Large (17.7bn) 0 No activity — 50%+
Healthcare Services Large (17.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (17.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (17.3bn) 0 No activity — 0–15%
Loading...